Cypher sirolimus-eluting coronary stent: Pivotal; marketed in Europe

In the double-blind European E-SIRIUS trial in 352 patients, 92% of Cypher patients had event-free survival vs. 77% of control patients at 270 days (p<0.001). No difference was seen between 2 differen...